|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|
| Assets | |
| Cash and cash equivalents (Note 5) | |
| Trade receivables and other assets (Note 6) | |
| Investments (Note 7) | |
| Total current assets | |
| Investment in associates (Note 9) | |
| Royalty interests | |
| Property and equipment | |
| Total non-current assets | |
| Total Assets | |
| Liabilities | |
| Current liabilities [abstract] | |
| Accounts payable and accrued liabilities (Note 10) | |
| Warrant liability (Note 11) | |
| Total current liabilities | |
| Non-current liabilities [abstract] | |
| Borrowings (Note 12) | |
| Deferred income tax liability (Note 13) | |
| Total non-current liabilities | |
| Total Liabilities | |
| Shareholders' Equity | |
| Share Capital (Note 14) | |
| Contributed Surplus | |
| Accumulated other comprehensive income ("AOCI") | |
| Deficit | |
| Total Shareholders' Equity | |
| Total Liabilities and Shareholders' Equity |
Loading...
